RESEARCH PAPER
Lipoprotein(a) in an adult sample from the Russian population: distribution and association with atherosclerotic cardiovascular diseases
 
More details
Hide details
1
National Medical Research Center of Cardiology, Russia
2
National Medical Research Center of Therapy and Preventive Medicine, Russia
3
Lomonosov Moscow State University, Russia
CORRESPONDING AUTHOR
Marat V Ezhov   

National Medical Research Center of Cardiology, 3rd Cherepkovskaya street, 15a, 121552, Moscow, Russia
Submission date: 2020-10-11
Final revision date: 2020-11-18
Acceptance date: 2020-12-02
Online publication date: 2021-03-15
 
 
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Lipoprotein(a) (Lp(a)) is recognized as an independent risk factor for atherosclerotic cardiovascular disease (ASCVD). The aim of this study was to estimate the distribution of Lp(a) levels in working age adults from the Russian population and to assess its association with ischemic heart disease (IHD), myocardial infarction (MI), stroke, diabetes mellitus (DM), and arterial hypertension (AH).

Material and methods:
This substudy of the population-based study “Epidemiology of Cardiovascular Diseases and their Risk Factors in Some Regions of the Russian Federation” (ESSE-RF) included 8461 subjects aged 25–64 years (63.7% women) without lipid-lowering drugs. Atherosclerotic cardiovascular disease was self-reported. Lp(a), apolipoproteins AI and B, and lipid and glucose levels in blood serum were determined.

Results:
The prevalence of Lp(a) ≥ 30 mg/dl was 20.5% and 23.0%, and prevalence of Lp(a) ≥ 50 mg/dl was 13.3% and 15.2%, in men and women, respectively. An association of Lp(a) with IHD, MI, and AH, but not with stroke and DM, was shown. A cut-off level of Lp(a) of 9 mg/dl was determined, above which there was increased frequency of MI (by 59.2%, p = 0.02), IHD (by 33.4%, p < 0.001), and AH (by 11.6%, p < 0.001). In the multivariate analysis only the association of Lp(a) with IHD (1.19 (1.01–1.41), p = 0.038) and MI (1.57 (1.06–2.38), p = 0.028) remained significant.

Conclusions:
Lipoprotein(a) level ≥ 30 mg/dl was detected in every fifth adult aged 25–64 years. Increased risk of MI and IHD starts at an Lp(a) serum level above 9 mg/dl.

eISSN:1896-9151
ISSN:1734-1922